Early Access — free while we kick the tires
EdgarHawk

Goddard Janie

Director

Director
2 filings analyzed · 1 company · Latest 2025-12-15

Companies

Company Buys Sells Direction
ULTRALIFE CORP ULBI 2 0 Net buying

Activity

December 2025
2025-12-15 ULTRALIFE CORP ULBI
low
Buy
1,739 shares
$9,999
Significance 3/10

Director Janie Goddard buys 1,739 shares of ULBI at $5.75, adding to 7.7K share position; stock down -37.0% from 52-week high.

Director Janie Goddard purchased 1,739 shares at $5.75, increasing her stake by 29.3% to 7.7K shares. The stock has declined significantly, trading at -37.0% from its 52-week high of $9.13 and down 15.1% over the past 90 days, though it has recovered 3.4% in the past month. Her prior three purchases at ULBI show a mixed record: the most recent buy from June 2025 returned +12.2% over 30 days, but historical 90-day returns have been negative, with zero of her three prior ULBI trades producing positive 90-day returns. The company itself faces headwinds with negative net income of $-1.2M against $43.4M in quarterly revenue, and a P/E of 57.50. This buy occurs during a period of material stock weakness and against a backdrop of the insider's own poor timing on this ticker over a multi-year period.

June 2025
2025-06-13 ULTRALIFE CORP ULBI
low
Buy
1,548 shares
$11,889
Significance 4/10

Director Goddard Janie purchases 1,548 shares of ULBI at $7.68; stock now -35.4% from 52-week high, 0 of 2 prior ULBI buys showed positive 90d returns.

Goddard Janie, a director, purchased 1,548 shares at $7.68, bringing her holdings from 4,381 to 5,929 shares—a 35.3% increase in her position. The current price of $7.74 is 35.4% below the 52-week high of $11.98, placing the purchase in a phase where the stock has retreated significantly from recent peaks. Examining her same-ticker history at ULBI, both of her two prior purchases—on 2024-06-07 and 2023-09-11—showed negative 90-day returns (-6.5% and -12.0%, respectively), with a 0% timing win rate at this ticker, suggesting a consistent pattern of purchasing before further declines rather than at inflection points. The company's fundamentals show modest revenue growth of 3.7% year-over-year and a P/E of 24.19, with recent quarterly net income at $1.9M on revenue of $50.7M, indicating a mature profile without exceptional growth momentum to support the prior trading pattern reversal.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access